Summary
Ganga Pharmaceuticals share holding pattern reports the following shareholding: Ganga Pharmaceuticals Total Promoters is at 50.91%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.00%, and Retail at 49.09%. This breakdown provides a quick snapshot of ownership distribution for Ganga Pharmaceuticals share holding pattern in 2026-27.
Ganga Pharmaceuticals FAQs
As of 05-2026, the promoter shareholding in Ganga Pharmaceuticals stands at 50.91% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Ganga Pharmaceuticals is 0% and 0% respectively.
The retail shareholding of the Ganga Pharmaceuticals is 49.09%.
Changes in shareholding patterns of Ganga Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Ganga Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Ganga Pharmaceuticals Associated Pages
